| Issue Date | Title | Author(s) |
| 2019-10-29 | Patients' clinical information requirements to apply the STOPP/START criteria | Carvalho, R; Lavrador, M; Cabral, AC; Verissimo, MT; Figueiredo, I; Fernandez-Llimos, F; Margarida Castel-Branco, M |
| 2015-01-01 | Opportunities and challenges for the nasal administration of nanoemulsions | Comfort, C; Garrastazu, G; Pozzoli, M; Sonvico, F |
| 2017-01-01 | Nephrotoxicity in rats exposed to paracetamol: The protective role of moralbosteroid, a steroidal glycoside | Gupta, G; Chellappan, DK; Kikuchi, IS; Pinto, TDJA; Pabreja, K; Agrawal, M; Singh, Y; Tiwari, J; Duaf, K |
| 2017-06-01 | Evaluation of in vitro and in vivo anti-urolithiatic activity of silver nanoparticles containing aqueous leaf extract of Tragia involucrata | Velu, V; Das, M; Raj N, AN; Dua, K; Malipeddi, H |
| 2008-03-12 | Structure and organization of phospholipid/polysaccharide nanoparticles | Gerelli, Y; Di Bari, MT; Deriu, A; Cantu, L; Colombo, P; Como, C; Motta, S; Sonvico, F; May, R |
| 2013-08-01 | Priorization of facilitators for the implementation of medication review with follow-up service in Spanish community pharmacies through exploratory factor analysis | Gil, MI; Benrimoj, SI; Martínez-Martínez, F; Cardero, M; Gastelurrutia, MA |
| 2019-05-01 | Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study | Hart, MR; Biesecker, BB; Blout, CL; Christensen, KD; Amendola, LM; Bergstrom, KL; Biswas, S; Bowling, KM; Brothers, KB; Conlin, LK; Cooper, GM; Dulik, MC; East, KM; Everett, JN; Finnila, CR; Ghazani, AA; Gilmore, MJ; Goddard, KAB; Jarvik, GP; Johnston, JJ; Kauffman, TL; Kelley, WV; Krier, JB; Lewis, KL; McGuire, AL; McMullen, C; Ou, J; Plon, SE; Rehm, HL; Richards, CS; Romasko, EJ; Miren Sagardia, A; Spinner, NB; Thompson, ML; Turbitt, E; Vassy, JL; Wilfond, BS; Veenstra, DL; Berg, JS; Green, RC; Biesecker, LG; Hindorff, LA |
| 2015-01-01 | Fabrication of curcumin micellar nanoparticles with enhanced anti-cancer activity | Lee, WH; Bebawy, M; Loo, CY; Luk, F; Mason, RS; Rohanizadeh, R |
| 2014-01-01 | Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation | Ullah, MA; Loh, Z; Gan, WJ; Zhang, V; Yang, H; Li, JH; Yamamoto, Y; Schmidt, AM; Armour, CL; Hughes, JM; Phipps, S; Sukkar, MB |
| 2018-09-01 | The role of distress tolerance, anxiety sensitivity, and intolerance of uncertainty in predicting hoarding symptoms in a clinical sample | Grisham, JR; Roberts, L; Cerea, S; Isemann, S; Svehla, J; Norberg, MM |
